The 3-year progression-free survival was also higher in this group but did not reach statistical significance.
← all excerpts
The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal Cancer.
1
—
—
The 3-year progression-free survival was also higher in this group but did not reach statistical significance.